Alto Neuroscience, Inc.

General ticker "ANRO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $584.7M (TTM average)

Alto Neuroscience, Inc. follows the US Stock Market performance with the rate: 52.8%.

Estimated limits based on current volatility of 3.2%: low 29.90$, high 31.86$

Factors to consider:

  • Total employees count: 68 (-10.5%) as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Clinical trial failure, No operating history, Labor/talent shortage/retention, Regulatory and compliance, Manufacturing scale up
  • Current price 12.0% above estimated high
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [8.58$, 26.78$]
  • 2026-12-31 to 2027-12-31 estimated range: [4.85$, 16.18$]

Similar symbols

Short-term ANRO quotes

Long-term ANRO plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $37.81MM $68.61MM $66.36MM
Operating Income $-37.81MM $-68.61MM $-66.36MM
Non-Operating Income $1.50MM $7.18MM $3.13MM
Interest Expense $1.37MM $1.38MM $2.47MM
R&D Expense $30.29MM $47.00MM $45.62MM
Income(Loss) $-36.30MM $-61.43MM $-63.24MM
Net Income(Loss)* $-36.30MM $-61.43MM $-63.24MM
Stockholders Equity $-71.67MM $151.46MM $151.14MM
Assets $86.63MM $177.54MM $184.69MM
Operating Cash Flow $-33.45MM $-47.42MM $-51.77MM
Capital expenditure $0.47MM $2.08MM $0.02MM
Investing Cash Flow $-0.47MM $-2.08MM $-0.02MM
Financing Cash Flow $68.13MM $135.69MM $60.08MM
Earnings Per Share** $-1.35 $-2.50 $-2.19

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.